GLI2 and melanoma: In order to find new GLI transcriptional targets that could be considered for combination therapy of melanoma, we performed RNA sequencing on melanoma cell lines with overexpressed GLI1, GLI2, and GLI3 and coupled the data with ChIP sequencing results on endogenous GLI1, GLI2, and GLI3 proteins for additional confirmation of direct GLI targets.